Literature DB >> 24422142

Mechanisms of osteoclast-dependent bone formation.

Anna Teti1.   

Abstract

Should we believe that osteoclasts are only involved in bone resorption? What about their contribution to bone formation? In this article I will review evidence that bone formation can be regulated by osteoclasts. Why is this? Likely because in the physiologic condition of bone remodeling, bone resorption and formation are balanced, and there is no better way to control this equilibrium than through a concerted action between the two cell types. Although the influence of osteoblasts on osteoclastic bone resorption is well documented and consolidated over time, what osteoclasts do to regulate osteoblast activity is still matter of intense investigation. The original hypothesis that all is in the osteoblast-seeking factors stored in the bone matrix, released and activated during bone resorption, is now being challenged by several studies, suggesting that osteoclasts are also capable of producing 'clastokines' that regulate osteoblast performance. Indeed, several of them have been demonstrated to orchestrate osteoclast-osteoblast activities. However, we are probably still at the dawn of a new era, and future work will tell us whether any of these clastokines can be exploited to stimulate bone formation and rebalance bone remodeling in skeletal diseases.

Entities:  

Year:  2013        PMID: 24422142      PMCID: PMC3872977          DOI: 10.1038/bonekey.2013.183

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  61 in total

Review 1.  Bone modeling and remodeling.

Authors:  Ego Seeman
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

2.  Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Authors:  Patrick Quint; Ming Ruan; Larry Pederson; Moustapha Kassem; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

Review 3.  Bone development: overview of bone cells and signaling.

Authors:  Anna Teti
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

4.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts.

Authors:  R O Oreffo; G R Mundy; S M Seyedin; L F Bonewald
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

Review 5.  Advances in the regulation of osteoclasts and osteoclast functions.

Authors:  B F Boyce
Journal:  J Dent Res       Date:  2013-08-01       Impact factor: 6.116

6.  Parathyroid hormone binding to cultured avian osteoclasts.

Authors:  A Teti; R Rizzoli; A Zambonin Zallone
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

7.  TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts.

Authors:  Kuniaki Ota; Patrick Quint; Ming Ruan; Larry Pederson; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

8.  Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.

Authors:  Susannah O'Sullivan; Dorit Naot; Karen Callon; Fran Porteous; Anne Horne; Diana Wattie; Maureen Watson; Jill Cornish; Peter Browett; Andrew Grey
Journal:  J Bone Miner Res       Date:  2007-11       Impact factor: 6.741

9.  Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice.

Authors:  Aline Heilmann; Thorsten Schinke; Ronny Bindl; Tim Wehner; Anna Rapp; Melanie Haffner-Luntzer; Astrid Liedert; Michael Amling; Anita Ignatius
Journal:  J Orthop Res       Date:  2013-07-01       Impact factor: 3.494

Review 10.  Osteoclasts; culprits in inflammatory osteolysis.

Authors:  Steven L Teitelbaum
Journal:  Arthritis Res Ther       Date:  2005-11-29       Impact factor: 5.156

View more
  37 in total

1.  Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model.

Authors:  Mikiya Sawa; Shigeyuki Wakitani; Naosuke Kamei; Shinji Kotaka; Nobuo Adachi; Mitsuo Ochi
Journal:  J Bone Miner Metab       Date:  2017-06-28       Impact factor: 2.626

Review 2.  [Regulation of bone metabolism in osteoporosis : novel drugs for osteoporosis in development].

Authors:  F Jakob; F Genest; G Baron; U Stumpf; M Rudert; L Seefried
Journal:  Unfallchirurg       Date:  2015-11       Impact factor: 1.000

Review 3.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

4.  Design of hydrogels to stabilize and enhance bone morphogenetic protein activity by heparin mimetics.

Authors:  Soyon Kim; Zhong-Kai Cui; Paul Jay Kim; Lawrence Young Jung; Min Lee
Journal:  Acta Biomater       Date:  2018-03-26       Impact factor: 8.947

5.  The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis.

Authors:  Takashi Izawa; Rieko Arakaki; Hiroki Mori; Takaaki Tsunematsu; Yasusei Kudo; Eiji Tanaka; Naozumi Ishimaru
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

Review 6.  DC-STAMP: A Key Regulator in Osteoclast Differentiation.

Authors:  Ya-Hui Chiu; Christopher T Ritchlin
Journal:  J Cell Physiol       Date:  2016-06-14       Impact factor: 6.384

7.  OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism.

Authors:  Laleh Ardeshirpour; Cristina Dumitru; Pamela Dann; John Sterpka; Joshua VanHouten; Wonnam Kim; Paul Kostenuik; John Wysolmerski
Journal:  Endocrinology       Date:  2015-05-11       Impact factor: 4.736

8.  Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.

Authors:  Mohamed Essameldin Abdelgawad; Jean-Marie Delaisse; Maja Hinge; Pia Rosgaard Jensen; Ragad Walid Alnaimi; Lars Rolighed; Lars H Engelholm; Niels Marcussen; Thomas Levin Andersen
Journal:  Histochem Cell Biol       Date:  2016-02-09       Impact factor: 4.304

Review 9.  Osteoblast-osteoclast interactions.

Authors:  Xiao Chen; Zhongqiu Wang; Na Duan; Guoying Zhu; Edward M Schwarz; Chao Xie
Journal:  Connect Tissue Res       Date:  2017-03-21       Impact factor: 3.417

Review 10.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.